A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2011
11/03/2011	WO2011136469A2 Pharmaceutical composition using connective tissue growth factor
11/03/2011	WO2011136400A1 Tumor-specific promoter and oncolytic virus vector comprising the same
11/03/2011	WO2011136399A1 Use of pdgf-r inhibitors for the treatment of lymph node metastasis of gastric cancer
11/03/2011	WO2011136378A1 Grafting material for genetic and cell therapy
11/03/2011	WO2011136369A1 Cationic lipid
11/03/2011	WO2011136368A1 Cationic lipid
11/03/2011	WO2011136319A1 Anticancer agent
11/03/2011	WO2011136247A1 Novel heteroaryl monocyclic pyrimidine derivative
11/03/2011	WO2011135869A1 Novel muc1 antibody
11/03/2011	WO2011135784A1 Anti-brain-tumor drug
11/03/2011	WO2011135520A1 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders
11/03/2011	WO2011135393A1 Autologous biological cancer vaccine
11/03/2011	WO2011135376A1 Pyrazolyl quinazoline kinase inhibitors
11/03/2011	WO2011135351A1 Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases
11/03/2011	WO2011135294A1 Method, device and system for targetted cell lysis
11/03/2011	WO2011135259A1 Pyrido[3,2-d]pyrimidine derivatives, processes for preparing same and therapeutic uses thereof
11/03/2011	WO2011135140A1 Method for the delivery of oligonucleotides
11/03/2011	WO2011135067A1 Modified binding proteins inhibiting the vegf-a receptor interaction
11/03/2011	WO2011134954A1 Anticancer steroidal lactones unsaturated in position 7 (8)
11/03/2011	WO2011134831A1 Pyrazole compounds as jak inhibitors
11/03/2011	WO2011134420A1 Detection and modulation of slit and roundabount (robo) mediated lymph vessel formation and uses thereof
11/03/2011	WO2011134368A1 Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof
11/03/2011	WO2011134280A1 Compounds as agonists of s1p1 receptors
11/03/2011	WO2011134275A1 Metal complexes of thiourea and their derivatives as metal delivering anti-cancer and anti-inflammatory agents
11/03/2011	WO2011134140A1 Pyrimidinyl indole compounds
11/03/2011	WO2011134023A1 Inhibition of glioma
11/03/2011	WO2011112689A3 Salts of an indazolylpyrrolotriazine
11/03/2011	WO2011108008A3 Antibody for targeted induction of apoptosis, cdc and adcc mediated killing of cancer cells, tbl-cln1
11/03/2011	WO2011098839A3 Di -aspirin derivatives for use in the treatment of colorectal cancer
11/03/2011	WO2011082400A3 Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
11/03/2011	WO2011082290A3 Formulations from natural products, turmeric, and aspirin
11/03/2011	WO2011068934A3 Vaccine against neoplastic or cancerous lesions caused by human papillomavirus (hpv), procedures, uses and methods
11/03/2011	WO2011066453A3 Pacap and related proteins in the treatment of cancer
11/03/2011	WO2011066378A3 Antagonists of il-6 to prevent or treat thrombosis
11/03/2011	WO2011065677A3 Pharmaceutical composition for treating cancer
11/03/2011	WO2011062437A3 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
11/03/2011	WO2011062372A3 2, 4, 7 -substituted thieno [3, 2 -d] pyrimidine compounds as protein kinase inhibitors
11/03/2011	WO2011059294A3 Anticancer and immunity-enhancing composition containing morphinan alkaloids as active ingredients
11/03/2011	WO2011056037A3 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts
11/03/2011	WO2011056021A3 Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis
11/03/2011	WO2011055991A3 A novel myxobacteria strain and a method for preparing epothilone using the same
11/03/2011	WO2011052919A3 Novel alpha-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition for an immune adjuvant, containing the derivatives as active ingredients
11/03/2011	WO2011050344A3 Cancer immunotherapy and method of treatment
11/03/2011	WO2011047097A3 Inhibition of trem receptor signaling with peptide variants
11/03/2011	WO2011034394A3 Oxaliplatin nanoparticles and method for preparing same
11/03/2011	WO2011020117A3 Methods of treating cancer using neurotrophin retargeted endopeptidases
11/03/2011	WO2010120414A3 Diazeniumdiolated phosphorylcholine polymers for nitric oxide release
11/03/2011	US20110271358 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
11/03/2011	US20110271357 Colon disease targets and uses thereof
11/03/2011	US20110270156 High shear application in medical therapy
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110270011 Use of opioids or opioid mimetics for the treatment of resistant cancer patients
11/03/2011	US20110269950 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
11/03/2011	US20110269947 Apo-2 ligand/trail formulations
11/03/2011	US20110269842 Compositions comprising cb receptor agonists, uses thereof and methods for their preparation
11/03/2011	US20110269840 Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde
11/03/2011	US20110269838 Novel processes and pure polymorphs
11/03/2011	US20110269829 Non-Aqueous Taxane Pro-Emulsion Formulations and Methods of Making and Using the Same
11/03/2011	US20110269824 Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancer
11/03/2011	US20110269819 Methods and compositions for targeting skip
11/03/2011	US20110269815 Methods of reducing cellular proliferation by inhibiting acsvl3
11/03/2011	US20110269812 Novel benzylidene-indolinone and their medical and diagnostic uses
11/03/2011	US20110269809 Spiroindolinone pyrrolidines
11/03/2011	US20110269808 Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases
11/03/2011	US20110269800 P38 map kinase inhibitors
11/03/2011	US20110269797 Anln protein as an endocrine treatment predictive factor
11/03/2011	US20110269790 Novel thienopyridines as pharmacologically active agents
11/03/2011	US20110269789 Compositions and Methods for Achieving Sustained Therapeutic Drug Concentrations in a Subject
11/03/2011	US20110269788 Spiro-oxindole-derivatives as sodium channel blockers
11/03/2011	US20110269774 Pyrazolylaminopyridines as inhibitors of fak
11/03/2011	US20110269773 Dihydrofuro pyrimidines as akt protein kinase inhibitors
11/03/2011	US20110269772 Axl kinase inhibitors
11/03/2011	US20110269771 Pyridazinone derivatives
11/03/2011	US20110269767 Novel Polymorphic Forms of 3-(1--6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile Hydrochloride Salt and Processes of Manufacturing Thereof
11/03/2011	US20110269765 Pyridazinone derivatives
11/03/2011	US20110269760 Tubulin inhibitors
11/03/2011	US20110269759 Pyrimidine compounds as delta opioid receptor modulators
11/03/2011	US20110269758 Naphthyridinones as protein kinase inhibitors
11/03/2011	US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011	US20110269756 Benzothiazolone derivatives
11/03/2011	US20110269749 Tricyclic carbamate jak inhibitors
11/03/2011	US20110269740 Jak kinase modulating compounds and methods of use thereof
11/03/2011	US20110269739 Kinase inhibitors
11/03/2011	US20110269738 Compounds
11/03/2011	US20110269732 Drug discovery methods
11/03/2011	US20110269730 Metal Complexes of Thiourea and Derivatives as Metal Delivering Anti-Cancer and Anti-Inflammatory Agents
11/03/2011	US20110269728 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
11/03/2011	US20110269713 Bryostatin analogues and methods of making and using thereof
11/03/2011	US20110269710 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
11/03/2011	US20110269709 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269707 Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation
11/03/2011	US20110269706 Hydroxamic Acid Derivatives
11/03/2011	US20110269705 Quinolone compound and pharmaceutical composition
11/03/2011	US20110269699 Cancer therapy
11/03/2011	US20110269698 Novel Cyclic Pentadepsipeptide Derivative and Fusarium Strain Producing The Same
11/03/2011	US20110269697 Organoarsenic compounds and methods for the treatment of cancer
11/03/2011	US20110269696 Inhibitors of iaps
11/03/2011	US20110269692 Alpha-fetoprotein peptides and uses thereof
11/03/2011	US20110269691 Compositions and Methods for Treating Pigmentary Conditions and Melanoma
11/03/2011	US20110269689 High penetration compositions and their applications

1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 2211